A 31-year-old Hispanic man presented with 5 days of right lower quadrant abdominal pain. His past medical history was notable for AIDS, antiretroviral medication noncompliance, multiple opportunistic infections (pulmonary tuberculosis, oral candidiasis, herpes zoster), and polysubstance abuse (methamphetamine and alcohol). The patient was an unemployed construction worker who emigrated from Veracruz, Mexico, 9 years earlier. His physical examination was notable for mild-to-moderate right lower quadrant abdominal tenderness. Laboratory results revealed a white blood cell count of 5600 cells/L with 63% neutrophils and 4% eosinophils, but were otherwise normal. CD4 count was 38 cells/L and HIV viral load was 175,232 copies/mL. An initial computed tomograph of his abdomen showed thickening of the terminal ileum and base of the cecum ( Figure A, arrow) . Colonoscopy revealed a terminal ileum that was diffusely ulcerated and inflamed for 5 cm with a fistula of the terminal ileum to the cecal base ( Figure  B , arrowhead points to fistula, arrow points to appendiceal orifice). Blood, urine, and stool bacterial and fungal cultures were negative. Serologic testing was negative for Aspergillus galactomannan antigen, Coccidioidies complement fixation and immunodiffusion, Cryptococcal antigen screen, Toxoplasmosis immunoglobulin (Ig)G and IgM antibody, Entamoeba histolytica antigen, and rapid plasma reagin. Urine Histoplasma antigen screen, stool ova and parasite, stool stain for Cryptosporidium and Isospora, and stool and sputum acid-fast bacilli smear and Mycobacterium tuberculosis direct test were negative. A cytomegalovirus shell vial culture and a general viral culture were negative. Pathologic specimens showed granulomatous ileitis/colitis with budding fungus (Figure C, Gomori's methenamine silver stain; original magnification, ϫ40; inset shows a close up of the organism). Because the fungal infection could not be identified, the patient was empirically treated with fluconazole. However, 1 month later, patient's symptoms did not improve.
mucosa carry the risk of distant metastasis years after complete resection. Radical esophagectomy with 3-field lymphadenectomy is the treatment of choice when feasible. The effectiveness of adjuvant chemotherapy, radiotherapy, and immunotherapy is controversial. The mean survival time after operation is 10 -14 months. Microscopic colitis (MC) is characterized by chronic, watery diarrhea. Typically, colonoscopy reveals normal-appearing colonic mucosa. Biopsy findings may indicate either lymphocytic colitis (LC), with increased intraepithelial lymphocytes (Ͼ20 lymphocytes per 100 surface epithelial cells), or collagenous colitis (CC), characterized by a thick subepithelial collagen band (Ͼ10 m). The cause of MC is unknown. Medications found to have a high likelihood of causing MC include acarbose, aspirin, lansoprazole, nonsteroidal anti-inflammatory drugs, ranitidine, sertraline, ticlopidine, cyclo3fort, and cirkan. 1 The first cases of lansoprazole-induced MC were published in 2001 after a national formulary change from omeprazole to lansoprazole in the VA hospital system. A recently published case series and systematic review of cases of lansoprazole-induced MC found a median time of symptom onset after lansoprazole initiation of 28 days in LC and 60 days in CC. 2 Macroscopic findings such as linear ulcers and submucosal hemorrhages were more common in lansoprazole-induced CC (72.2%) than in lansoprazole-induced LC (6.6%). Other reports of macroscopic findings in MC describe associations with nonsteroidal anti-inflammatory drugs, aspirin, lansoprazole, recent antibiotics, or infection. 3 One retrospective, case-control study found an adjusted odds ratio of 4.5 (95% confidence interval, 2-9.5) for the association between MC and PPI use in the preceding 180 days of MC diagnosis. 2 The prevalence of use of individual PPIs in this cohort was omeprazole (40%), esomeprazole (22.8%), pantoprazole (28.6%), rabeprazole (5.7%), and lansoprazole (2.8%).
Management of drug-induced colitis includes removal of the offending agent. In the case of lansoprazole-induced MC, the median time for symptom resolution after drug removal was 7 days for LC and 14 for CC. 2 If symptoms do not resolve, treatment can include antidiarrheals, cholestyramine, budesonide, or systemic corticosteroids, depending on the severity of disease.
We suspect our patient had lansoprazole-induced MC. It is conceivable that his symptom resolution was owing to the corticosteroid course rather than discontinuation of the lansoprazole. However, in Ͼ11 months he has not had symptom relapse, his time course is consistent with other published cases of lansoprazole-induced MC, and other potential etiologies of diarrhea were ruled out. Furthermore, he has remained on aspirin, which is also known to be associated with MC, without relapse.
